$0.600000
-0.0010-0.17%
At Close: -
$0.650000
0.058.33%
After Hours: Jul 24, 7:27 AM EDT
15 minutes delayed
Comments
Loading...
HCW Biologics (NASDAQ:HCWB) Stock, Analyst Ratings, Price Targets, Forecasts
HCW Biologics Inc has a consensus price target of $7.5 based on the ratings of 4 analysts. The high is $9 issued by EF Hutton on June 1, 2023. The low is $4 issued by Maxim Group on March 24, 2022. The 3 most-recent analyst ratings were released by EF Hutton on June 1, 2023, April 19, 2023, and March 30, 2023, respectively. With an average price target of $9 between EF Hutton, there's an implied 1284.62% upside for HCW Biologics Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
EF Hutton
EF Hutton
JonesTrading
Maxim Group
1calculated from analyst ratings
Analyst Ratings for HCW Biologics
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 06/01/2023 | Buy Now | 1284.62% | EF Hutton | Tony Butler | → $9 | Assumes | → Buy | Get Alert |
| 04/19/2023 | Buy Now | 1284.62% | EF Hutton | Constantine Davides | → $9 | Reiterates | → Buy | Get Alert |
| 03/30/2023 | Buy Now | 1284.62% | EF Hutton | Constantine Davides | → $9 | Reiterates | → Buy | Get Alert |
| 03/23/2023 | Buy Now | 1284.62% | EF Hutton | Constantine Davides | → $9 | Reiterates | → Buy | Get Alert |
| 11/08/2022 | Buy Now | 1130.77% | JonesTrading | Soumit Roy | → $8 | Initiates | → Buy | Get Alert |
| 03/24/2022 | Buy Now | 515.38% | Maxim Group | Michael Okunewitch | → $4 | Initiates | → Buy | Get Alert |
| 11/19/2021 | Buy Now | 1438.46% | EF Hutton | Constantine Davides | — | Initiates | → Buy | Get Alert |
FAQ
What is the target price for HCW Biologics (HCWB) stock?
The latest price target for HCW Biologics (NASDAQ:HCWB) was reported by EF Hutton on June 1, 2023. The analyst firm set a price target for $9.00 expecting HCWB to rise to within 12 months (a possible 1284.62% upside). 0 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for HCW Biologics (HCWB)?
The latest analyst rating for HCW Biologics (NASDAQ:HCWB) was provided by EF Hutton, and HCW Biologics their buy rating.
When was the last upgrade for HCW Biologics (HCWB)?
There is no last upgrade for HCW Biologics
When was the last downgrade for HCW Biologics (HCWB)?
There is no last downgrade for HCW Biologics.
When is the next analyst rating going to be posted or updated for HCW Biologics (HCWB)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of HCW Biologics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for HCW Biologics was filed on June 1, 2023 so you should expect the next rating to be made available sometime around June 1, 2024.
Is the Analyst Rating HCW Biologics (HCWB) correct?
While ratings are subjective and will change, the latest HCW Biologics (HCWB) rating was a with a price target of $0.00 to $9.00. The current price HCW Biologics (HCWB) is trading at is $0.65, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.